342 related articles for article (PubMed ID: 21594579)
1. Novel ARF/p53-independent senescence pathways in cancer repression.
Chan CH; Gao Y; Moten A; Lin HK
J Mol Med (Berl); 2011 Sep; 89(9):857-67. PubMed ID: 21594579
[TBL] [Abstract][Full Text] [Related]
2. Senescence and aging: the critical roles of p53.
Rufini A; Tucci P; Celardo I; Melino G
Oncogene; 2013 Oct; 32(43):5129-43. PubMed ID: 23416979
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
4. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
[TBL] [Abstract][Full Text] [Related]
5. A new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation.
Lee SJ; Lee SH; Yoon MH; Park BJ
Neoplasia; 2013 Jul; 15(7):727-37. PubMed ID: 23814485
[TBL] [Abstract][Full Text] [Related]
6. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
7. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP
Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851
[TBL] [Abstract][Full Text] [Related]
8. CDK2 transcriptional repression is an essential effector in p53-dependent cellular senescence-implications for therapeutic intervention.
Zalzali H; Nasr B; Harajly M; Basma H; Ghamloush F; Ghayad S; Ghanem N; Evan GI; Saab R
Mol Cancer Res; 2015 Jan; 13(1):29-40. PubMed ID: 25149358
[TBL] [Abstract][Full Text] [Related]
9. A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis.
Sinha VC; Qin L; Li Y
Mol Cancer Res; 2015 Feb; 13(2):231-8. PubMed ID: 25253740
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
11. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Chen Z; Carracedo A; Lin HK; Koutcher JA; Behrendt N; Egia A; Alimonti A; Carver BS; Gerald W; Teruya-Feldstein J; Loda M; Pandolfi PP
Sci Signal; 2009 Aug; 2(84):ra44. PubMed ID: 19690330
[TBL] [Abstract][Full Text] [Related]
12. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
Chen D; Shan J; Zhu WG; Qin J; Gu W
Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of ARF regulation that control senescence and cancer.
Ko A; Han SY; Song J
BMB Rep; 2016 Nov; 49(11):598-606. PubMed ID: 27470213
[TBL] [Abstract][Full Text] [Related]
14. ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.
Forys JT; Kuzmicki CE; Saporita AJ; Winkeler CL; Maggi LB; Weber JD
Cell Rep; 2014 Apr; 7(2):514-526. PubMed ID: 24726362
[TBL] [Abstract][Full Text] [Related]
15. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
16. The p53 transcriptional response across tumor types reveals core and senescence-specific signatures modulated by long noncoding RNAs.
Tesfaye E; Martinez-Terroba E; Bendor J; Winkler L; Olivero C; Chen K; Feldser DM; Zamudio JR; Dimitrova N
Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326251
[TBL] [Abstract][Full Text] [Related]
17. YPEL3, a p53-regulated gene that induces cellular senescence.
Kelley KD; Miller KR; Todd A; Kelley AR; Tuttle R; Berberich SJ
Cancer Res; 2010 May; 70(9):3566-75. PubMed ID: 20388804
[TBL] [Abstract][Full Text] [Related]
18. p53-induced apoptosis as a safeguard against cancer.
Asker C; Wiman KG; Selivanova G
Biochem Biophys Res Commun; 1999 Nov; 265(1):1-6. PubMed ID: 10548481
[TBL] [Abstract][Full Text] [Related]
19. The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway.
Martinelli P; Bonetti P; Sironi C; Pruneri G; Fumagalli C; Raviele PR; Volorio S; Pileri S; Chiarle R; McDuff FK; Tusi BK; Turner SD; Inghirami G; Pelicci PG; Colombo E
Blood; 2011 Jun; 117(24):6617-26. PubMed ID: 21518927
[TBL] [Abstract][Full Text] [Related]
20. Targeting LINC00673 expression triggers cellular senescence in lung cancer.
Roth A; Boulay K; Groß M; Polycarpou-Schwarz M; Mallette FA; Regnier M; Bida O; Ginsberg D; Warth A; Schnabel PA; Muley T; Meister M; Zabeck H; Hoffmann H; Diederichs S
RNA Biol; 2018; 15(12):1499-1511. PubMed ID: 30499379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
